Macrocure Ltd. Provides Update on Futility Analysis for Phase III Clinical Trial of CureXcell(R) in Venous Leg Ulcers

World News: . []

PETACH TIKVA Israel Aug 19 2015 GLOBE NEWSWIRE) -- Macrocure Ltd Macrocure or the "Company") NASDAQMCUR a clinical-stage biotechnology company focused on advancing its novel therapeutic platform to address chronic and hard-to-heal wound s, toda...

More news and information about Macrocure

Published By:

Globe Newswire: 23:40 GMT Wednesday 19th August 2015

Published: .

Search for other references to "macrocure" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us